
Neuland
NEULANDLAB.NSNeuland Laboratories Price (NEULANDLAB.NS)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
12,829,889
(0)%Description
Neuland Laboratories Limited manufactures and sells active pharmaceutical ingredients (APIs) in India, Europe, the United States, and internationally. The company's APIs are used in various therapeutic areas, including antiasthmatics, cardiovasculars, antifungal, anticonvulsants, central nervous system, fluoroquinolones, antipsychotic, antibacterial, and anti-parkinson. It also provides custom manufacturing solutions, as well as peptide synthesis services. The company was incorporated in 1984 and is headquartered in Hyderabad, India. Read More
Sector: Healthcare
- Previous Close Fetching Data...
- Range $5540.1-18100
- Market Cap 141.70B
- Enterprise Value No Data
- Avg Volume Fetching Data...
- P/E Ratio Fetching Data...
- Dividend Yield Fetching Data...
Industry: Drug Manufacturers - Specialty & Generic
- ceo: Mr. Davuluri Sucheth Rao
- IPO Date: October, 13, 2008
- Country: IN
- Currency: INR
- Headquaters: No Data
- Employees: 1643
- Revenue from each product or segment:
Product or Segment | Value: | % - Total | Last 3Y: |
---|

- Revenue by Region
Product or Segment | Value: | % - Total | Last 3Y: |
---|
